StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Tuesday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

NYSE:CO opened at $1.50 on Tuesday. The firm’s 50 day simple moving average is $1.36 and its 200 day simple moving average is $1.36. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The company has a market cap of $182.33 million, a PE ratio of 2.34 and a beta of 0.16.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.